Biologic license application

Results: 93



#Item
71[removed]Federal Register / Vol. 77, No[removed]Friday, May 18, [removed]Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and

[removed]Federal Register / Vol. 77, No[removed]Friday, May 18, [removed]Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and

Add to Reading List

Source URL: www.gpo.gov

Language: English - Date: 2014-05-29 17:04:43
7242 USCA § [removed]U.S.C.A. § 262 Page 2  UNITED STATES CODE ANNOTATED

42 USCA § [removed]U.S.C.A. § 262 Page 2 UNITED STATES CODE ANNOTATED

Add to Reading List

Source URL: www.selectagents.gov

Language: English - Date: 2009-08-10 07:59:55
73

PDF Document

Add to Reading List

Source URL: www.cms.gov

Language: English - Date: 2013-08-07 14:25:14
74

PDF Document

Add to Reading List

Source URL: www.fda.gov

Language: English
75

PDF Document

Add to Reading List

Source URL: www.fda.gov

Language: English
76This document is scheduled to be published in the Federal Register on[removed]and available online at http://federalregister.gov/a[removed], and on FDsys.gov[removed]P DEPARTMENT OF HEALTH AND HUMAN SERVICES

This document is scheduled to be published in the Federal Register on[removed]and available online at http://federalregister.gov/a[removed], and on FDsys.gov[removed]P DEPARTMENT OF HEALTH AND HUMAN SERVICES

Add to Reading List

Source URL: s3.amazonaws.com

Language: English - Date: 2013-10-31 11:13:45
77CDER Therapeutic Biologic Billable List Mmm yy

CDER Therapeutic Biologic Billable List Mmm yy

Add to Reading List

Source URL: www.fda.gov

Language: English
78Microsoft PowerPoint - Courtney.PublicHealthLawConf[removed]no photos.pptx

Microsoft PowerPoint - Courtney.PublicHealthLawConf[removed]no photos.pptx

Add to Reading List

Source URL: www.fda.gov

Language: English
798883  Federal Register / Vol. 77, No[removed]Wednesday, February 15, [removed]Notices TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1—Continued 351(k) Application for biosimilars (42 U.S.C. 262(k[removed]l)(6)(C) .............

8883 Federal Register / Vol. 77, No[removed]Wednesday, February 15, [removed]Notices TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1—Continued 351(k) Application for biosimilars (42 U.S.C. 262(k[removed]l)(6)(C) .............

Add to Reading List

Source URL: www.gpo.gov

Language: English - Date: 2013-05-23 13:09:03
80Microsoft Word - Final User Fee Guidance Cleared by OCC _3-31-05_.doc

Microsoft Word - Final User Fee Guidance Cleared by OCC _3-31-05_.doc

Add to Reading List

Source URL: www.fda.gov

Language: English